Spatial Domain
Spatial Domain (Tier 1)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__87_C8,14 | Lung | Primary cancer | 3,518 | Tumor/Malignant | 78.5% | 0.99 | 0.03 |
| NSCLC_38242124__IMC__87_C8,15 | Lung | Primary cancer | 2,755 | Immune | 25.6% | 0.34 | 1.00 |
| NSCLC_38242124__IMC__87_C8,16 | Lung | Primary cancer | 888 | Stromal | 29.7% | 0.39 | 0.95 |
| NSCLC_38242124__IMC__87_C8,17 | Lung | Primary cancer | 734 | Other | 33.9% | 0.34 | 0.95 |
| NSCLC_38242124__IMC__87_C8,2 | Lung | Primary cancer | 2,429 | Tumor/Malignant | 48.7% | 0.89 | 0.35 |
| NSCLC_38242124__IMC__87_C8,3 | Lung | Primary cancer | 1,975 | Immune | 35.2% | 0.33 | 0.99 |
| NSCLC_38242124__IMC__87_C8,4 | Lung | Primary cancer | 2,879 | Tumor/Malignant | 34.3% | 0.56 | 0.78 |
| NSCLC_38242124__IMC__87_C8,5 | Lung | Primary cancer | 2,271 | Stromal | 52.7% | 0.92 | 0.25 |
| NSCLC_38242124__IMC__87_C8,6 | Lung | Primary cancer | 3,518 | Tumor/Malignant | 42.7% | 0.95 | 0.22 |
| NSCLC_38242124__IMC__87_C8,7 | Lung | Primary cancer | 3,142 | Tumor/Malignant | 62.2% | 0.98 | 0.07 |
| NSCLC_38242124__IMC__87_C8,8 | Lung | Primary cancer | 2,268 | Immune | 33.1% | 0.29 | 1.01 |
| NSCLC_38242124__IMC__87_C8,9 | Lung | Primary cancer | 2,466 | Tumor/Malignant | 29.0% | 0.93 | 0.22 |
| NSCLC_38242124__IMC__88_A1,1 | Lung | Primary cancer | 3,920 | Tumor/Malignant | 59.6% | 0.91 | 0.29 |
| NSCLC_38242124__IMC__88_A1,10 | Lung | Primary cancer | 2,846 | Tumor/Malignant | 76.9% | 0.99 | 0.06 |
| NSCLC_38242124__IMC__88_A1,11 | Lung | Primary cancer | 2,755 | Tumor/Malignant | 46.0% | 0.96 | 0.12 |
| NSCLC_38242124__IMC__88_A1,12 | Lung | Primary cancer | 3,172 | Tumor/Malignant | 45.6% | 0.74 | 0.58 |
| NSCLC_38242124__IMC__88_A1,13 | Lung | Primary cancer | 2,621 | Tumor/Malignant | 66.1% | 0.98 | 0.09 |
| NSCLC_38242124__IMC__88_A1,14 | Lung | Primary cancer | 1,569 | Tumor/Malignant | 44.6% | 0.95 | 0.22 |
| NSCLC_38242124__IMC__88_A1,15 | Lung | Primary cancer | 2,801 | Tumor/Malignant | 39.3% | 0.93 | 0.24 |
| NSCLC_38242124__IMC__88_A1,16 | Lung | Primary cancer | 2,975 | Tumor/Malignant | 65.1% | 0.98 | 0.10 |
Spatial Domain (Tier 2)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__87_C8,14 | Lung | Primary cancer | 3,518 | Tumor/Malignant | 74.3% | 0.99 | 0.03 |
| NSCLC_38242124__IMC__87_C8,15 | Lung | Primary cancer | 2,755 | Stromal | 21.2% | 0.29 | 1.08 |
| NSCLC_38242124__IMC__87_C8,16 | Lung | Primary cancer | 888 | Stromal | 33.8% | 0.56 | 0.89 |
| NSCLC_38242124__IMC__87_C8,17 | Lung | Primary cancer | 734 | Other | 24.1% | 0.45 | 0.94 |
| NSCLC_38242124__IMC__87_C8,2 | Lung | Primary cancer | 2,429 | Tumor/Malignant | 37.2% | 0.94 | 0.24 |
| NSCLC_38242124__IMC__87_C8,3 | Lung | Primary cancer | 1,975 | Tumor/Malignant | 23.1% | 0.86 | 0.46 |
| NSCLC_38242124__IMC__87_C8,4 | Lung | Primary cancer | 2,879 | Tumor/Malignant | 32.9% | 0.93 | 0.31 |
| NSCLC_38242124__IMC__87_C8,5 | Lung | Primary cancer | 2,271 | Stromal | 40.5% | 0.94 | 0.18 |
| NSCLC_38242124__IMC__87_C8,6 | Lung | Primary cancer | 3,518 | Tumor/Malignant | 30.2% | 0.77 | 0.66 |
| NSCLC_38242124__IMC__87_C8,7 | Lung | Primary cancer | 3,142 | Tumor/Malignant | 61.9% | 0.98 | 0.06 |
| NSCLC_38242124__IMC__87_C8,8 | Lung | Primary cancer | 2,268 | Tumor/Malignant | 25.2% | 0.50 | 0.99 |
| NSCLC_38242124__IMC__87_C8,9 | Lung | Primary cancer | 2,466 | Tumor/Malignant | 28.0% | 0.93 | 0.21 |
| NSCLC_38242124__IMC__88_A1,1 | Lung | Primary cancer | 3,920 | Tumor/Malignant | 33.6% | 0.75 | 0.59 |
| NSCLC_38242124__IMC__88_A1,10 | Lung | Primary cancer | 2,846 | Tumor/Malignant | 76.4% | 0.99 | 0.06 |
| NSCLC_38242124__IMC__88_A1,11 | Lung | Primary cancer | 2,755 | Tumor/Malignant | 46.2% | 0.96 | 0.12 |
| NSCLC_38242124__IMC__88_A1,12 | Lung | Primary cancer | 3,172 | Tumor/Malignant | 46.1% | 0.96 | 0.17 |
| NSCLC_38242124__IMC__88_A1,13 | Lung | Primary cancer | 2,621 | Tumor/Malignant | 66.3% | 0.98 | 0.09 |
| NSCLC_38242124__IMC__88_A1,14 | Lung | Primary cancer | 1,569 | Tumor/Malignant | 44.7% | 0.94 | 0.22 |
| NSCLC_38242124__IMC__88_A1,15 | Lung | Primary cancer | 2,801 | Tumor/Malignant | 32.8% | 0.97 | 0.14 |
| NSCLC_38242124__IMC__88_A1,16 | Lung | Primary cancer | 2,975 | Tumor/Malignant | 55.2% | 1.00 | 0.02 |
Spatial Domain (Tier 3)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__87_C8,14 | Lung | Primary cancer | 3,518 | Tumor/Malignant cell | 78.7% | 0.99 | 0.03 |
| NSCLC_38242124__IMC__87_C8,15 | Lung | Primary cancer | 2,755 | Tumor/Malignant cell | 22.7% | 0.85 | 0.46 |
| NSCLC_38242124__IMC__87_C8,16 | Lung | Primary cancer | 888 | Fibroblast | 23.8% | 0.74 | 0.68 |
| NSCLC_38242124__IMC__87_C8,17 | Lung | Primary cancer | 734 | Other | 32.3% | 0.61 | 0.74 |
| NSCLC_38242124__IMC__87_C8,2 | Lung | Primary cancer | 2,429 | Tumor/Malignant cell | 49.1% | 0.88 | 0.36 |
| NSCLC_38242124__IMC__87_C8,3 | Lung | Primary cancer | 1,975 | Tumor/Malignant cell | 30.1% | 0.78 | 0.56 |
| NSCLC_38242124__IMC__87_C8,4 | Lung | Primary cancer | 2,879 | Tumor/Malignant cell | 40.8% | 0.90 | 0.39 |
| NSCLC_38242124__IMC__87_C8,5 | Lung | Primary cancer | 2,271 | Fibroblast | 49.1% | 0.92 | 0.26 |
| NSCLC_38242124__IMC__87_C8,6 | Lung | Primary cancer | 3,518 | Tumor/Malignant cell | 44.3% | 0.94 | 0.24 |
| NSCLC_38242124__IMC__87_C8,7 | Lung | Primary cancer | 3,142 | Tumor/Malignant cell | 62.1% | 0.98 | 0.07 |
| NSCLC_38242124__IMC__87_C8,8 | Lung | Primary cancer | 2,268 | Tumor/Malignant cell | 32.5% | 0.78 | 0.64 |
| NSCLC_38242124__IMC__87_C8,9 | Lung | Primary cancer | 2,466 | Tumor/Malignant cell | 28.4% | 0.93 | 0.22 |
| NSCLC_38242124__IMC__88_A1,1 | Lung | Primary cancer | 3,920 | Tumor/Malignant cell | 55.6% | 0.93 | 0.26 |
| NSCLC_38242124__IMC__88_A1,10 | Lung | Primary cancer | 2,846 | Tumor/Malignant cell | 76.2% | 0.99 | 0.06 |
| NSCLC_38242124__IMC__88_A1,11 | Lung | Primary cancer | 2,755 | Tumor/Malignant cell | 46.1% | 0.96 | 0.12 |
| NSCLC_38242124__IMC__88_A1,12 | Lung | Primary cancer | 3,172 | Tumor/Malignant cell | 56.8% | 0.93 | 0.24 |
| NSCLC_38242124__IMC__88_A1,13 | Lung | Primary cancer | 2,621 | Tumor/Malignant cell | 66.1% | 0.98 | 0.09 |
| NSCLC_38242124__IMC__88_A1,14 | Lung | Primary cancer | 1,569 | Tumor/Malignant cell | 42.8% | 0.95 | 0.20 |
| NSCLC_38242124__IMC__88_A1,15 | Lung | Primary cancer | 2,801 | Tumor/Malignant cell | 38.3% | 0.93 | 0.23 |
| NSCLC_38242124__IMC__88_A1,16 | Lung | Primary cancer | 2,975 | Tumor/Malignant cell | 67.0% | 0.97 | 0.12 |